Redsense Medical AB (publ) (RDSNF)
OTCMKTS
· Delayed Price · Currency is USD
0.5100
-0.5400 (-51.43%)
At close: Aug 2, 2024
Redsense Medical AB Revenue
In the year 2024, Redsense Medical AB had annual revenue of 28.77M SEK with 12.74% growth. Redsense Medical AB had revenue of 12.69M in the quarter ending December 31, 2024, with 55.97% growth.
Revenue
28.77M SEK
Revenue Growth
+12.74%
P/S Ratio
3.89
Revenue / Employee
5.75M SEK
Employees
5
Market Cap
10.11M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.77M | 3.25M | 12.74% |
Dec 31, 2023 | 25.52M | 8.76M | 52.32% |
Dec 31, 2022 | 16.75M | 410.00K | 2.51% |
Dec 31, 2021 | 16.34M | -757.98K | -4.43% |
Dec 31, 2020 | 17.10M | 2.87M | 20.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
SS Innovations International | 20.65M |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |